Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease. - Wikidata - wikimedia - TriplyDB

Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

http://www.wikidata.org/entity/Q42908536

about

Inflammation in depression: is adiposity a cause?Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration Prothrombin Kringle-2: A Potential Inflammatory Pathogen in the Parkinsonian Dopaminergic System Implications of glial nitric oxide in neurodegenerative diseases Bridge between neuroimmunity and traumatic brain injury Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases Protective Effects of Streblus asper Leaf Extract on H2O2-Induced ROS in SK-N-SH Cells and MPTP-Induced Parkinson's Disease-Like Symptoms in C57BL/6 Mouse Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.Proteomic modeling for HIV-1 infected microglia-astrocyte crosstalk.Plasma DNA Mediate Autonomic Dysfunctions and White Matter Injuries in Patients with Parkinson's Disease The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases.Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders Evidence of inflammatory system involvement in Parkinson's disease.Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases.Intravitreous delivery of the corticosteroid fluocinolone acetonide attenuates retinal degeneration in S334ter-4 rats.Differential effect of Helicobacter pylori eradication on time-trends in brady/hypokinesia and rigidity in idiopathic parkinsonism.Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression Substance P exacerbates dopaminergic neurodegeneration through neurokinin-1 receptor-independent activation of microglial NADPH oxidase Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease Eryptosis as a marker of Parkinson's disease Registered bioimaging of nanomaterials for diagnostic and therapeutic monitoring.Temporal dynamic changes of connexin 43 expression in C6 cells following lipopolysaccharide stimulation.The mechanism of antidepressant-like effects of piroxicam in rats.Ganoderma lucidum Protects Dopaminergic Neuron Degeneration through Inhibition of Microglial Activation.A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats Oxidative stress-dependent changes in immune responses and cell death in the substantia nigra after ozone exposure in rat.Neuroprotective Properties of the Standardized Extract from Camellia sinensis (Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson's Disease.Oxidative stress and microglial cells in Parkinson's disease Neuroprotective effect of nerolidol against neuroinflammation and oxidative stress induced by rotenone.Neuron-astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice.Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures.Do all of the neurologic diseases in patients with DNA repair gene mutations result from the accumulation of DNA damage?Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol.Genotype and age at Parkinson disease diagnosis.

P2860

Q24635451-68AEC408-D16A-4BD7-8836-83219276B5F2 Q24649627-CE2DDAB8-DB10-484E-8376-B3BBF9AF8F82 Q26738336-3A5B086A-70A3-42CD-8B2E-826216977F68 Q26782894-D931CFF8-28D2-42C9-8F4C-ADD7A2E91BCE Q26827612-4FDF0FAB-5415-42F2-9ACC-6EDDF52E2E33 Q26849232-3F2EF6B5-0CF6-4070-82B2-19AB1D62B45B Q28277871-52877E16-540A-45D5-B062-302FC0372AFA Q28388335-CB9A8A99-A2A7-4962-9E7C-90F743F75590 Q30393313-F95EC82B-D765-45BA-A257-7AD3302A2C07 Q31109638-433D99E2-73C5-454F-9BF2-61D043B94962 Q33346280-B524944A-A218-445A-899F-9DD3BFDFD997 Q33364851-79BE7088-405E-453A-8243-AE4328DD07E7 Q33659621-8A35B950-1CF0-463A-82F2-8B9E9ED408A2 Q33670805-BD213EFC-9090-43BB-9CA7-C9C995ED2530 Q33890818-8EBC5418-28B3-4037-993F-F9E34366FE95 Q33892744-2E120DA6-9773-45EC-9DD1-1EB89BAF42AE Q34014053-10E9451E-A476-4AED-8C5D-1F383BA04ED7 Q34022619-4405BB04-9DC4-4ADC-B02C-7DB24087DBD6 Q34032330-04AD3C74-E6BE-4326-818F-B7463113ADDC Q34071942-C87073F3-7966-4083-9BB2-DA5D5DC4EA12 Q34090453-0DE70CD8-C4B7-42D0-9782-5C559DA80288 Q34162782-3AFED534-4FDA-4F93-8DB3-9DA719AE836E Q34224832-D4A60283-953E-4978-B3A5-6253625C36A0 Q34585744-D4F43205-3E32-46C1-A46B-787A65E95C6B Q34639915-0B8E6C7C-0353-4AD4-BFC4-1D273FF2A700 Q34984362-46998D42-0859-4063-9F2D-F81FCDA6BD55 Q35056335-F2168A13-617B-4139-A5A2-24B2DEA76CAC Q35104866-61DCD415-7C0B-4A64-B233-ACBCEC1F03F0 Q35554450-2CD1F8F8-5EB3-42AF-8379-7FCD85D89775 Q35569568-9E419386-9FFA-4D5E-B4C4-7652708E66E1 Q35808114-83614B80-1F07-46DA-80E0-8E1D5BD2D401 Q35876266-03E72BE5-9768-4C9C-A9B2-D7BADA7FE3DE Q36109494-2FEB7BE8-E575-456F-B936-CEFC64AC97D5 Q36238937-1A3EB234-43FE-45F8-A5A1-CF6A3ED026DF Q36326816-7A37F617-A433-4F4C-B183-7911FCCF49F4 Q36373813-BB0EBA9C-C09C-4A65-A8EF-31F14CDC91E1 Q36512406-0EA983A2-CAD1-474B-9622-2188C03003A5 Q36690915-309696A7-21C3-4CBE-85D6-EBF8BC4C1290 Q36704078-2D33DA7A-ECFA-4888-9036-44AD0766391F Q36729049-24345F0E-1FC1-4712-A318-72E3ECF91535

P2860

Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

http://www.wikidata.org/entity/Q42908536

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

@en

Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

@nl

type

label

Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

@en

Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

@nl

prefLabel

Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

@en

Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

@nl

P1433

Q42908536-0E2E30F5-1EA9-4014-A24B-06670A867D20

P1476

Q42908536-A0D9C962-3577-4439-9F80-8CE9FB8EE0B7

P2093

Q42908536-240996A4-0E7E-4FCC-AE08-FBF9E7E183D9

Q42908536-2D1D5AFC-93B4-47E6-AE8A-A6EFBEE78C60

Q42908536-3070BB40-209B-428E-BA44-1D2EFE2E451E

Q42908536-4279BD8F-E190-4171-A0A7-4C8F8788332C

Q42908536-47D7FB22-BCFA-4A58-A27A-71C8E6B9F5B8

Q42908536-4D643FBF-ABFC-464B-AADE-B963EBDE9B26

Q42908536-98BB2B69-1FFC-4FB7-938B-4D67ECDC522E

Q42908536-D1D39223-48AA-4C17-947C-F262C7B514BF

P2860

Q42908536-01463401-556E-4E84-9FC9-2726F8AC4EB9

Q42908536-024039D4-A674-478A-939F-EA780A9D4553

Q42908536-04609B70-E739-47BE-B59D-851CA4CB72EF

Q42908536-0489704F-89D9-4445-92CF-5D32FA3DCA70

Q42908536-051F52C4-0B67-4375-AADC-75E5DC1056E6

Q42908536-05A218A1-F5BD-4B3E-B8B2-3FADDD0A0952

Q42908536-08D93921-8199-4255-AF50-16B06C4542D4

Q42908536-09E8E606-425D-4B35-8054-8F4849E2CC40

Q42908536-0A5D30DA-1776-4795-B9CD-41158587E277

Q42908536-0AF0298E-6896-4827-9D69-773F0E4C90E3

P304

Q42908536-8C1B3360-6A9A-43E7-9598-298B52BD3FD7

P31

Q42908536-4585F8DF-9380-423C-AD9A-FDB511D5D27C

P356

Q42908536-B8C9E922-CD42-4BB5-A242-DA65FD606ACF

P433

Q42908536-AEC870EE-B67C-4A8B-BE12-9D7F723A289A

P478

Q42908536-35EDA5F9-04A6-40DB-AAF1-0506631FF1C0

P577

Q42908536-EFCE9952-E38E-4078-841B-573960CD1D74

P5875

Q42908536-57E7A9F3-45DB-47A5-8E9A-871FD904CCA9

P698

Q42908536-480BCD14-7CBF-4C50-8215-25898FD9636E

P921

Q42908536-27B22128-5781-4A16-829D-1424CA7BDBE3

Q42908536-85ee2bea-3f5a-46af-8bef-0d0867b7303b

P932

Q42908536-07389B0A-CBA4-4829-9FD7-363A24F81513

P356

J.CNR.2006.09.006

P1433

Clinical neuroscience research

P1476

Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease.

@en

P2093

Chad Laurie

http://www.w3.org/2001/XMLSchema#string

Eric J Benner

http://www.w3.org/2001/XMLSchema#string

Howard E Gendelman

http://www.w3.org/2001/XMLSchema#string

Irena Kadiu

http://www.w3.org/2001/XMLSchema#string

Khader Hasan

http://www.w3.org/2001/XMLSchema#string

Mark Thomas

http://www.w3.org/2001/XMLSchema#string

Michael D Boska

http://www.w3.org/2001/XMLSchema#string

R Lee Mosley

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

Intraneuronal dopamine-quinone synthesis: A review

The Antioxidants and Pro-Antioxidants Network: An Overview

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system.

Functional requirement for class I MHC in CNS development and plasticity

Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.

Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease

Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition

alpha-Synuclein locus triplication causes Parkinson's disease

P304

261-281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CNR.2006.09.006

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223604705

http://www.w3.org/2001/XMLSchema#string

P698

18060039

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

1831679

http://www.w3.org/2001/XMLSchema#string